The use of non-drug approaches to the treatment of premenstrual syndrome (PMS) is reviewed. Pyridoxine (vitamin B6) in doses of 40-100 mg twice daily is now widely used, especially in less severe cases. Current views on the mechanisms involved are described. Recent work on the use of the essential fatty acid, gamma-linolenic acid, (2-3 g oil of evening primrose per day) has shown encouraging preliminary responses, and a doubleblind placebo controlled study is in progress. Other nutritional approaches can be supportive, especially in milder cases but are unlikely to provide complete relief. Preliminary evidence suggests that certain allergies may deteriorate premenstrually, therefore some premenstrual benefits may be gained by identifying and avoiding the relevant substances.
INTRODUCTION
Premenstrual syndrome (PMS) is a very common problem which may affect women at various times from the onset of puberty until the menopause but is probably commonest in the 30--45 age group. It is characterised by mental and physical symptoms which only occur in the second half of the menstrual cycle and disappear within 24-48 hr of the onset of menstruation. The individual symptoms can be very varied but the commonest are mood changes, swelling of abdomen, fingers and ankles, breast discomfort and headaches. Other symptoms frequently reported are lack of co-ordination, impaired concentration, loss of sex drive, food cravings and acne-like blotches on face and neck.
Many theories exist as to the aetiology of PMS and are discussed in various reviews (Brush, 1977 (Brush, , 1979 Halbreich and Endicott, 1981; Reid and Yen, 1981) .
While it is clear that the periodicity of PMS is produced by the hormonal changes of the luteal phase of the menstrual cycle, there is less agreement as to the underlying hormonal or metabolic defects which are responsible for the varied symptoms. There is indirect evidence to suggest that a relative insufficiency of pyridoxine in the hypothalamic region may be involved (Brush, 1977 (Brush, , 1979 (Brush, , 1983a and recently a partial block in 66-desaturase activity (Brush, Watson and Horrobin, in preparation) has been thought to be important as it may lead to imbalance between the various prostaglandins. There is other evidence to implicate the prostaglandins Gakubowicz, 1983) and there are theoretical grounds to involve the endorphins (Halbreich and Endicott, 1981; Reid and Yen, 1981) .
Over the last seven years, pyridoxine has been used on an increasing scale in the medical and self-help treatment of PMS with considerable success, especially in the milder and less complicated cases. Recently, gamma-linolenic acid in the form of oil of evening primrose has been used to by-pass the 203 partial 66-desaturase deficiency, and promising preliminary results have been obtained in PMS sufferers. In this paper, these approaches are discussed and some comments are made on other nutritional approaches, such as special diets, some of which are designed to avoid various food allergies.
PYRIDOXINE
Pyridoxine (vitamin B6) was used by Baumblatt and Winston (1970) and Adams et al. (1973) in the treatment of depression due to the contraceptive pill. Good results were obtained with 40 mg twice daily and pyridoxine is still widely used by those who wish to stay on the pill but find side-effects, such as depression, nausea and breast tenderness. Giles (1975) tried pyridoxine (50-80 mg/d~y) in the treatment of PMS patients and obtained encouraging results. At his suggestion, we repeated his work on a larger number of patients and fully confirmed his findings (Kerr, 1977) , the overall response rate being 70%. Since then, we have continued to use pyridoxine in the treatment of PMS, either alone or in combination with agents such as dydrogesterone (Brush, 1983b) , gamma-linolenic acid (Brush, 1982c) , or spironolactone (Vellacott, 1983) . The dose of pyridoxine ranges from 40-100 mg twice daily, usually from three days before the expected onset of symptoms to the second day of menstruation. A single blind placebo controlled study (Day et al., 1983) confirmed 70% response rate obtained by Kerr (1977) . Unpublished experience of this department suggested the responses can be increased still further by the use of doses of 150-200 mg/day. A recent report from U.S.A. (Abraham and Hargrove, 1980) advocates the use of a 500 mg long-acting preparation but this is probably an unnecessarily large amount.
No significant side effects have been established apart from a small incidence of excessive gastric acidity which is only seen above 150 mg/day. There are no known contra-indications, apart from the rare situation of patients receiving Ldopa therapy.
Pyridoxine, in the form of pyridoxal phosphate (PLP), is a co-factor in a large number of important enzymic reactions in various tissues of the body and it is, therefore, difficult to assess the precise mechanisms by which it produces helpful results in PMS treatment. However, it is well established that PLP is a co-factor in the biosynthetic pathways leading to the formation of both serotonin and dopamine in the hypothalamus. Alterations in serotonin levels are known to have significant effects on mood, and dopamine is the final link in the regulation of prolactin secretion by the pituitary. Thus, lack of PLP is potentially liable to influence the varied processes controlled by serotonin and prolactin. This does not explain the cylical nature of PMS and in a recent 'two level' theory (Brush, 1982a (Brush, ,b, 1983 hypothalamic changes have been suggested as the underlying cause with the cyclicity being produced by the normal or nearly normal levels of progesterone and oestrogen in the luteal phase, perhaps by sensitising the hypothalamus to the underlying dysfunction.
Among the many other metabolic processes in which PLP takes part as a cofactor, one of particular interest, is the biosynthesis of the essential fatty acid dihomogamma-linolenic acid (DGLA) from cis-linoleic acid. DGLA can, in turn, be metabolised to prostaglandin E1 or arachadonic acid (directly or via the membrane phospholipid pools) which, in turn, can be converted to prostaglandins Fza and Ez, and other members of the 2 series prostaglandins. The implications of changes in PLP status in relation to EF A metabolism are far from fully understood due to the complexity of the pathways involved. The balance of prostaglandin E1 with the 2 series prostaglandins is clearly extremely important 204 in view of the powerful and opposing effects of the 1 and 2 series prostaglandins in many tissues of the body and their effects on endocrine and endocrine influenced systems, such as pituitary, ovary, breasts and kidney.
At present, there is no direct evidence on possible factors responsible for the postulated PLP lack in PMS. Indirect evidence suggests that in some cases, absorption of dietary pyridoxine could be inefficient. By analogy with 'pill'induced depression, there could also be hormone-induced changes in the levels of other PLP dependent enzymes. Either or both of these situations could lead to a local relative insufficiency of PLP in specialised organs, such as the hypothalamus.
GAMMA-LINOLENIC ACID
A very recent nutritional approach to the treatment of PMS is the use of the essential fatty acid, gamma-linolenic acid (GLA), in the form of evening primrose oil ('Efamol'). This oil, which is obtained from the seeds of the evening primrose plant, contains 8-9% GLA and is the richest known natural source. Other oils and certain other foods only contain very small amounts of GLA. So far, it has not been practicable to synthesize GLA commercially. Biosynthesis of GLA from dietary sources of cis-linoleic acid occurs only to a very limited extent in man (Brenner, 1974) . It seems likely that the conversion of cis-linoleic acid to GLA by the enzyme 66-desaturase is rather limited and very liable to interference by a number of external and other factors such as dietary cholesterol, saturated fats, alcohol and ageing (Horrobin, 1982) .
Further biosynthetic steps lead on from GLA to prostaglandin E1 (PGE1) via dihomogammalinolenic acid (DGLA). A limited amount of DGLA may be converted to arachidonic acid by the action of the 65-desaturase system and, thence, to various members of the 2 series prostaglandins. However, the largest amount of arachidonic acid is supplied directly from dietary sources. It appears that the ratio of PGE1 to the 2 series prostaglandins may be very important in a number of tissues and may be responsible for the symptoms seen in various conditions possibly including PMS.
The use of dietary supplements of GLA appears to be able to correct disordered biosynthesis of PGE1, and encouraging results are being obtained in various trials in progress.
Preliminary studies by Dr. D. F. Horrobin on a few women with PMS showed very useful improvement. An open study to assess dose levels, timing in the menstrual cycle, and acceptability was then carried out on 73 women with PMS (Brush, 1982c) . In most cases, the dose used was four 500 mg capsules of oil of evening primrose per day from three days before the expected onset of symptoms until the start of menstruation but, occasionally, six capsules per day were needed. The women participating had almost always failed one or more other treatments, such as progestogens and pyridoxine, but the results with oil of evening primrose were encouraging as approximately 60% reported excellent responses with relief of all symptoms, and a further 20% gave a useful partial response. The remaining 20% did not show improvement and, where possible, the reasons for this were followed up. The likelihood of a major placebo response to GLA is thought to be small due to the failure to respond to other treatments. Side effects were minimal and amounted to four episodes of shortlasting facial spots, and three complaints of excessive quietening of mood.
There is some evidence that pyridoxine, niacin, ascorbic acid, zinc (Horrobin, 1982) and magnesium (Horrobin, personal communication) may be co-factors necessary for optimum efficiency of the biosynthetic pathway from cis-linoleic acid to PGE1. In a few cases, supplementation of this type, in addition to GLA, was found helpful. In other studies, pyridoxine alone was used with GLA in attempts to maximise response but this combination was only used if pyridoxine alone had previously been shown to give little or no benefit. Despite some 205 useful preliminary findings, it is clear that further studies on the importance of these additional factors will be needed.
At present, a double-blind crossover study (6 X 500 mg Efamol per day versus placebo) is in progress, and further experience is being gained with Efamol on an open basis. The original series of 73 women (Brush, 1982c) has been extended to 117 women (Brush and Watson, unpublished) . The initial results show an excellent response in 60%, a partial response in 25% and no response in 15% of the participating women. In particular, the useful results with previously stubborn premenstrual breast discomfort with or without a fibrocystic component (Brush, 1982c) , have been maintained. They are also in agreement with the results of Preece et al. (1982) on cyclical benign breast disease. It should be noted that in severe cases of premenstrual breast conditions showing fibrocystic changes, it may take at least four months before significant improvement is seen. Unfortunately, even then there are some very stubborn cases which fail to respond to any combination of GLA and pyridoxine, and these may need treatment with danazol.
DIETARY METHODS
There is, as yet, no evidence that severe PMS can be effectively controlled by changes in the diet alone, although major nutritional supplements, such as pyridoxine and GLA, may be successful as described above. In particular, it is not practical to obtain enough pyridoxine or GLA from the diet to control severe PMS. Nevertheless, by attention to various dietary matters, it may be possible to improve the milder types of PMS. Furthermore, it is now beginning to be realised that certain allergies, including the so-called 'hidden' allergies, may become much worse premenstrually and, therefore, by excluding the offending foods, great improvement can be obtained.
A well balanced varied diet with plenty of fresh fruit and vegetables, wholemeal bread and adequate amounts of protein, should maintain good basic nutritional health. Such a diet should, of course, exclude white bread, various junk and/or convenience foods containing preservatives and colouring substances, and excessive amounts of coffee or tea. If such a diet is followed carefully and PMS symptoms persist, it should then be much easier to follow the effects of any further additions or deletions.
. Sometimes a salt-free diet is advocated for relief of PMS and certainly excessive use of sa~t should be discouraged. It is very unlikely that a salt-free diet will have any effect on more than the milder cases of PMS, but using only basic salt in cooking and taking none on the plate, can be worth trying, especially as it is probably beneficial to general health as well. This, of course, entails avoiding such pre-salted items as crisps, peanuts, certain biscuits, certain preserved types of fish and meats, pickles and other obviously salty items.
There is now some evidence that magnesium content of red blood cells may be low in PMS sufferers and dietary supplements of pyridoxine are thought to be helpful in maintaining magnesium levels . There are also suggestions that magnesium is a cofactor in GLA biosynthesis. As modest supplements of magnesium are safe and convenient, there would seem to be no reason why they should not be tried, especially if pyridoxine has not given enough relief.
There have been various anecdotal reports that calcium supplements may be helpful in PMS but no reliable reports are available. At present, there seems no reason to advocate such calcium supplements but, equally, no reason to condemn them, especially if taken in conventional amounts, either with or without magnesium.
A common problem in PMS is the so-called fluid retention, or bloating. 206 Although some PMS sufferers clearly retain excess water, as determined by weighing during and after the premenstrual phase, there are others who do not show a significant weight increase. They are probably redistributing body water due to changes in the permeability of the precapillary arterioles and, possibly, of the capillaries (Dunnigan, 1983) . Nutritional measures which might reasonably be thought likely to strengthen the walls of these small blood vessels are vitamin C, bioflavenoids, vitamin E and calcium. Preliminary experience in this laboratory suggests that vitamin C (500 mg/d), bio-flavenoids (as citrus pulp or 100 mg/d) and vitamin E (100-200 mg/d) may give some partial relief. Dunnigan (1983) reports that weight reduction in the obese subject helps relieve fluid retention and mentions other non-nutritional approaches to this problem.
Some workers, including Billig and Spaulding (1947) and Dalton (1977) , suggest that hypoglycaemia is very common in PMS, especially in women who do not eat regular meals. In our experience, hypoglycaemia can occur, though it is not as common as has been suggested by others, and may be relieved by a regime of light meals or snacks every three hours. It is important that the daily calorie intake remains unchanged if the PMS sufferer is concerned to maintain or reduce her present weight. There is now some evidence that agoraphobic sufferers suffer both hypoglycaemia and hyperventilation, and probably some women with PMS show mild degrees of hyperventilation at their worst times. This could account for some of the bizarre symptomatology occasionally seen.
FOOD ALLERGIES
It is now reasonably widely accepted that certain food allergies can be responsible for some mood changes, skin disorders, abdominal upsets, joint aches, and many other symptoms have been suggested (Randolph and Moss, 1980) . It is now becoming clear that these allergies can become worse premenstrually and, therefore, may be part of PMS or confused with it. The proper use of exclusion diets may lead to the identification of the offending foods and allow appropriate action to be taken.
DISCUSSION AND CONCLUSIONS
The treatment of PMS with pyridoxine, as described above, has now been found safe, acceptable and effective by many doctors and PMS sufferers. Doses of 40-100 mg twice daily are not expensive in comparison with other treatments, and this adds to its acceptability. Combination treatment of pyridoxine and other active agents are possible and can be very useful in difficult cases. The use of GLA, in the form of oil of evening primrose in PMS treatment, is at an early stage but results, so far, are promising. It is clear that diet alone will not supply enough pyridoxine and GLA to control PMS, and that supplements in the form of tablets or capsules respectively are necessary. The use of pyridoxine and GLA supplements opens the way to a nutritional 'non-drug' approach to the control of PMS which is obviously attractive to many PMS sufferers. A schematic representation of this nutritional approach is given in Figure 1 .
Several dietary factors, including adjustment of intake of salt, magnesium, calcium, vitamin C, bioflavenoids and vitamin E, may all be important in some circumstances. Measures to avoid hypoglycaemia are also likely to be most helpful. The preliminary evidence now available for the deterioration of certain food and other allergies during the premenstrual phase is stimulating further investigation into the mechanisms involved. Meanwhile, however, action to avoid the offending substances can usually clarify, and often greatly improve, the general pattern of PMS.
Further studies on all these varied nutritional and allergic factors in relation to PMS are urgently needed as they are likely to improve non-drug treatments for PMS still further. 207
